Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28444973)
Watch
English
PGR Expression
genetic variant
EXPRESSION
In more languages
edit
Statements
instance of
sequence variant
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
chromosome
human chromosome 11
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
genomic start
100900355
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
genomic end
101001255
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
biological variant of
PGR
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
positive therapeutic predictor for
tamoxifen
determination method
CIViC evidence level B
rating
CIViC 1-star trust rating
medical condition treated
breast cancer
statement disputed by
Biomarkers for the clinical management of breast cancer: international perspective
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/501
stated in
Biomarkers for the clinical management of breast cancer: international perspective
exemestane
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
medical condition treated
breast cancer
statement disputed by
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/502
stated in
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
tamoxifen
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
medical condition treated
breast cancer
statement disputed by
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/502
stated in
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
positive prognostic predictor for
breast cancer
determination method
CIViC evidence level B
rating
CIViC 3-star trust rating
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/500
stated in
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
negative prognostic predictor for
breast cancer
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/503
stated in
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
Identifiers
CIViC variant ID
210
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/210
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit